Agohob, Nakia .

HRN: 22-24-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/26/2023
11/01/2023
ORAL
1.9ml
TID
AGE
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: